Testing effectiveness (Phase 2)Study completedNCT04037358
What this trial is testing
RAdium-223 and SABR Versus SABR for Oligometastatic Prostate Cancers
Who this might be right for
Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 64